https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=39258717&retmode=xml&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09 392587172024112120241121
1440-179729122024DecNephrology (Carlton, Vic.)Nephrology (Carlton)SLC12A1 variant c.1684+1 G>A causes Bartter syndrome type 1 by promoting exon 13 skipping.801805801-80510.1111/nep.14390Bartter syndrome type 1, an autosomal recessive genetic disorder, is caused by pathogenic loss-of-function variants in the SLC12A1 gene. It is characterized by metabolic alkalosis and prenatal-onset polyuria leading to polyhydramnios.We identified pathogenic gene in a 12-day-old newborn boy with Bartter syndrome type 1 using whole-exome sequencing. Sanger sequencing validated the identified variants. A minigene assay was performed to investigate the effect of a novel splice site variant on pre-mRNA splicing.We found a compound heterozygous variants in the SLC12A1 gene, consisting of a known pathogenic missense mutation (NM_000338: c.769 G>A; p.Gly257Ser) and a novel splice site variant (c.1684+1 G>A). In silico predictions and an in vitro minigene splicing assay demonstrated that the splicing variant c.1684+1 G>A abolished a consensus splice donor site of SLC12A1 intron 13, resulting in complete exon 13 skipping, translational frameshift, and premature termination codon, ultimately leading to loss of SLC12A1 function.Using a cell-based in vitro assay, we revealed the aberrant effect of the pathogenic splicing variant SLC12A1 c.1684+1 G>A on pre-mRNA splicing. Our findings expand the gene mutation spectrum of Bartter syndrome type 1, providing a basis for genetic diagnosis and the development of genetic medicines.© 2024 Asian Pacific Society of Nephrology.YangWenkeWHenan Provincial People's Hospital, People's Hospital of Henan University, People's Hospital of Zhengzhou University, Zhengzhou, China.National Health Commission Key Laboratory of Birth Defects Prevention, Henan Provincial Key Laboratory of Genetic Diseases and Functional Genomics, Zhengzhou, China.LiYanjunYHenan Provincial People's Hospital, People's Hospital of Henan University, People's Hospital of Zhengzhou University, Zhengzhou, China.GuoZhenglongZHenan Provincial People's Hospital, People's Hospital of Henan University, People's Hospital of Zhengzhou University, Zhengzhou, China.National Health Commission Key Laboratory of Birth Defects Prevention, Henan Provincial Key Laboratory of Genetic Diseases and Functional Genomics, Zhengzhou, China.RenYanxinYHenan Provincial People's Hospital, People's Hospital of Henan University, People's Hospital of Zhengzhou University, Zhengzhou, China.National Health Commission Key Laboratory of Birth Defects Prevention, Henan Provincial Key Laboratory of Genetic Diseases and Functional Genomics, Zhengzhou, China.HuangJianmeiJHenan Provincial People's Hospital, People's Hospital of Henan University, People's Hospital of Zhengzhou University, Zhengzhou, China.National Health Commission Key Laboratory of Birth Defects Prevention, Henan Provincial Key Laboratory of Genetic Diseases and Functional Genomics, Zhengzhou, China.ZhaoHuiruHHenan Provincial People's Hospital, People's Hospital of Henan University, People's Hospital of Zhengzhou University, Zhengzhou, China.LiaoShixiuS0000-0002-4904-6128Henan Provincial People's Hospital, People's Hospital of Henan University, People's Hospital of Zhengzhou University, Zhengzhou, China.National Health Commission Key Laboratory of Birth Defects Prevention, Henan Provincial Key Laboratory of Genetic Diseases and Functional Genomics, Zhengzhou, China.engSBGJ202101003Major and Key Projects Jointly Constructed by Henan Province and Ministry of Science and TechnologySBGJ202302014Major and Key Projects Jointly Constructed by Henan Province and Ministry of Science and TechnologyZC20190149Scientific Research Startup Funds of Henan Provincial People's HospitalZC20220268Scientific Research Startup Funds of Henan Provincial People's HospitalCase ReportsJournal Article20240911
AustraliaNephrology (Carlton)96155681320-53580Solute Carrier Family 12, Member 10SLC12A1 protein, humanBartter syndrome, antenatal type 1IMHumansBartter SyndromegeneticsdiagnosisMaleExonsInfant, NewbornSolute Carrier Family 12, Member 1geneticsmetabolismPhenotypeRNA SplicingMutation, MissenseExome SequencingGenetic Predisposition to DiseaseBartter syndrome type 1SLC12A1 geneexon skippingminigenesplicing variant
202449202483020241121621202491112462024911735ppublish3925871710.1111/nep.14390REFERENCESFlorea L, Caba L, Gorduza EV. Genetic heterogeneity in Bartter syndrome: clinical and practical importance. Front Pediatr. 2022;10:908655.Arroyo JP, Kahle KT, Gamba G. The SLC12 family of electroneutral cation‐coupled chloride cotransporters. Mol Aspects Med. 2013;34:288‐298.Do C, Vasquez PC, Soleimani M. Metabolic alkalosis pathogenesis, diagnosis, and treatment: core curriculum 2022. Am J Kidney Dis. 2022;80:536‐551.Ravarotto V, Bertoldi G, Stefanelli LF, Nalesso F, Calò LA. Gitelman's and Bartter's syndromes: from genetics to the molecular basis of hypertension and more. Kidney Blood Press Res. 2022;47:556‐564.Nuñez‐Gonzalez L, Carrera N, Garcia‐Gonzalez MA. Molecular basis, diagnostic challenges and therapeutic approaches of Bartter and Gitelman syndromes: a primer for clinicians. Int J Mol Sci. 2021;22:11414.Sun M, Ning J, Xu W, et al. Genetic heterogeneity in patients with Bartter syndrome type 1. Mol Med Rep. 2017;15:581‐590.Han Y, Zhao X, Wang S, et al. Eleven novel SLC12A1 variants and an exonic mutation cause exon skipping in Bartter syndrome type I. Endocrine. 2019;64:708‐718.Marcoux AA, Tremblay LE, Slimani S, et al. Molecular characteristics and physiological roles of Na+–K+–Cl− cotransporter 2. J Cell Physiol. 2021;236:1712‐1729.Baralle D, Baralle M. Splicing in action: assessing disease causing sequence changes. J Med Genet. 2005;42:737‐748.Xin Q, Liu Q, Liu Z, et al. Twelve exonic variants in the SLC12A1 and CLCNKB genes alter RNA splicing in a minigene assay. Front Genet. 2022;13:961384.Adachi M, Asakura Y, Sato Y, et al. Novel SLC12A1 (NKCC2) mutations in two families with Bartter syndrome type 1. Endocr J. 2007;54:1003‐1007.Daga A, Majmundar AJ, Braun DA, et al. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int. 2018;93:204‐213.Guo Z, Huo X, Wu D, Hao B, Liao S. A novel variant of the KIF11 gene, c.2922G>T, is associated with microcephaly by affecting RNA splicing. Dev Neurosci. 2022;44:113‐120.Ji W, Foo JN, O'Roak BJ, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet. 2008;40:592‐599.Zhang J, Wei J, Jiang S, et al. Macula densa SGLT1‐NOS1‐tubuloglomerular feedback pathway, a new mechanism for glomerular hyperfiltration during hyperglycemia. J Am Soc Nephrol. 2019;30:578‐593.Lindeboom RGH, Vermeulen M, Lehner B, Supek F. The impact of nonsense‐mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy. Nat Genet. 2019;51:1645‐1651.Trcek T, Sato H, Singer RH, Maquat LE. Temporal and spatial characterization of nonsense‐mediated mRNA decay. Genes Dev. 2013;27:541‐551.You KT, Li LS, Kim NG, et al. Selective translational repression of truncated proteins from frameshift mutation‐derived mRNAs in tumors. PLoS Biol. 2007;5:e109.